Adage Capital Partners’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $21.3M | Sell |
|
|||||
|
2024
Q3 | $34.3M | Sell |
|
|||||
|
2024
Q2 | $63.2M | Sell |
|
|||||
|
2024
Q1 | $60.8M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $67.9M | Sell |
|
|||||
|
2023
Q2 | $75M | Buy |
|
|||||
|
2023
Q1 | $55.2M | Sell |
|
|||||
|
2022
Q4 | $87.5M | Sell |
|
|||||
|
2022
Q3 | $97.8M | Sell |
|
|||||
|
2022
Q2 | $94.8M | Buy |
|
|||||
|
2022
Q1 | $79.3M | Buy |
|
|||||
|
2021
Q4 | $58.5M | Buy |
|
|||||
|
2021
Q3 | $37M | Buy |
|
|||||
|
2021
Q2 | $28M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $51.1M | Sell |
|
|||||
|
2020
Q3 | $119M | Sell |
|
|||||
|
2020
Q2 | $176M | Sell |
|
|||||
|
2020
Q1 | $198M | Buy |
|
|||||
|
2019
Q4 | $140M | Sell |
|
|||||
|
2019
Q3 | $130M | Buy |
|
|||||
|
2019
Q2 | $182M | Sell |
|
|||||
|
2019
Q1 | $197M | Sell |
|
|||||
|
2018
Q4 | $256M | Buy |
|
|||||
|
2018
Q3 | $210M | Buy |
|
|||||
|
2018
Q2 | $140M | Buy |
|
|||||
|
2018
Q1 | $7.41M | Buy |
|